post-add

Artemis Reports Record Revenue & Margins; Expands With Third Tower & New Hospital Project In Raipur

Operational revenue stood at Rs 2,414 million, while EBITDA rose by 35.7 per cent to Rs 497 million, with margins climbing to 20.6 per cent from 16.3 per cent in Q2 FY24

Artemis Medicare Services (BSE: 542919 | NSE: ARTEMISMED) achieved record-breaking revenue and EBITDA margins in Q2 and H1 FY25, reflecting robust growth across its operational and financial metrics. 

In a press statement on Saturday, the company said that in Q2 FY25, consolidated gross revenue reached Rs 2,523 million, marking a 6.2 per cent year-on-year (Y-o-Y) increase. Operational revenue stood at Rs 2,414 million, while EBITDA rose by 35.7 per cent to Rs 497 million, with margins climbing to 20.6 per cent from 16.3 per cent in Q2 FY24. Profit After Tax (PAT) grew by 63.5 per cent to Rs 221 million, driven by economies of scale and operational efficiencies.

For the first half of FY25, consolidated operational revenue totaled Rs 4,646 million, up 6.9 per cent Y-o-Y. EBITDA surged by 37.2 per cent to Rs 903 million, while PAT increased by 66 per cent to Rs 387 million, with margins improving to 8.3 per cent from 5.4 per cent in H1 FY24.

At its Gurgaon flagship facility, Artemis reported a 7.8 per cent rise in net revenue to Rs 2,239 million. EBITDA margins improved to 22.3 per cent, compared to 18.4 per cent in the previous year. The hospital maintained a bed utilisation rate of 69.4 per cent, treated 99,803 patients, and conducted 3,498 surgeries in Q2 FY25. Revenue from international patients grew by 2.3 per cent, contributing 28 per cent to net revenue, while average revenue per occupied bed (ARPOB) increased by 3.1 per cent to Rs 78,800. The facility expanded operations with the launch of a third tower, set to be operationalised in phases.

Looking ahead, Artemis is extending its footprint into central India with a 300+ bed super-speciality hospital in Raipur. This project, part of a long-term Operations & Maintenance and Medical Services Agreement, is expected to be operational within a year, further enhancing the company’s regional presence.

Dr. Devlina Chakravarty, Managing Director of Artemis Medicare Services Ltd., remarked, “Our record-breaking performance in Q2 and H1 FY25 demonstrates the success of our strategic initiatives. The third tower launch and refined payer mix have driven industry-leading ARPOBs and improved margins. With the Raipur project, we aim to strengthen our reach and build a solid foundation for future growth.”

 

Also Read

Subscribe to our newsletter to get updates on our latest news